Rx oral solid opioids market share for morphine equivalents Canada 2017, by drug

In 2017, the prescription oral solid opioid morphine had a 14 percent share of the total market based on morphine equivalents sold in Canada. The opioid with the highest market share was oxycodone with 34 percent.

Percentage of the prescription oral solid opioid market in Canada based on morphine equivalents (MEQ) in 2017, by drug

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

January 2019

Region

Canada

Survey time period

2017

Supplementary notes

Morphine equivalents are a standardized measure used in this study to compare the relative potency of a milligram of each opioid to morphine.
Statistic includes prescription retail and hospital markets.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.